Atlas Trials

G2GBio, Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch G2GBio, Inc.

RecordFirmDate
Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept®) in Healthy Male Volunteers (NCT06127368)G2GBio, Inc.2024-01-03
Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults (NCT06095973)G2GBio, Inc.2023-10-24
Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers (NCT05525780)G2GBio, Inc.2022-08-26

Track G2GBio, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.